• Careers
    • Open Positions
    • Postdoctoral Training
    • Postdoctoral Association
    • Internships
  • Contact
La Jolla Institute for Immunology
  • About Us
    • Overview
      • History
      • President’s Message
      • Institute Facts
    • Our Team
      • Leadership
      • Faculty
        • Emeriti
        • LJI Scholars
        • Clinical Associates
      • Board of Directors
      • Scientific Advisory Board
    • Statements
      • LJI Diversity and Inclusion Statement
      • Vaccines
  • Labs
    • Altman Lab
    • Ay Lab
    • Benedict Lab
    • Cheroutre Lab
    • Croft Lab
    • Crotty Lab
    • Hedrick Lab
    • Hogan Lab
    • Kawakami Lab
    • Kronenberg Lab
    • Ley Lab
    • Peters Lab
    • Rao Lab
    • Saphire Lab
    • Schoenberger Lab
    • Sette Lab
    • Sharma Lab
    • Shresta Lab
    • Vijayanand Lab
    • von Herrath Lab
  • Research
    • Overview
    • COVID-19
    • Diseases (A-Z)
    • Research Centers
      • Center for Autoimmunity and Inflammation
      • Center for Cancer Immunotherapy
      • Center for Infectious Disease and Vaccine Research
    • Database of Immune Cell Epigenomics
    • Immune Epitope Database
    • Translational Research
    • Technology Development
    • Research Services
      • Bioinformatics
      • Clinical Studies
      • Cryo-EM
      • DLAC
      • Flow Cytometry
      • Microscopy & Histology
      • Next Generation Sequencing
    • Publications
  • News
    • Latest News
    • Behind the Science Blog
    • Media Inquiries
  • Seminars
    • Seminars
    • Life Without Disease Seminar Series
  • Immune Matters
  • Support
    • Overview
    • Giving Opportunities
      • The Tullie and Rickey Families SPARK Program
      • Center for Precision Immunotherapy
      • SURGE Program
      • Together for Asthma
    • Ways to Give
    • Vanguard Giving Society
    • Planned Giving
    • CARES Act
    • Advancement Team
    • Clinical Studies
    • DONATE
  • Careers
    • Open Positions
    • Postdoctoral Training
    • Postdoctoral Association
    • Internships
  • Contact
Support

Publications

Jul 9, 2009 Nat Immunol
Activin A programs the differentiation of human TFH cells
Locci M, Wu JE, Arumemi F, Mikulski Z, Sahlberg C, Miller AT, Crotty S
Jul 9, 2009 Mediators Inflamm
When insult is added to injury: crosstalk between ILCs and intestinal epithelium in IBD
van der Gracht E, Zahner S, Kronenberg M
Jun 30, 2009 Curr Opin Struct Biol
Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it.
Lee JE, Saphire EO.
Jun 7, 2009 Journal of Bioinformatics and Computational Biology (JBCB)
A fast and accurate algorithm for comparative analysis of metabolic pathways
F. Ay, T. Kahveci, and V. de Crecy-Lagard.
Apr 18, 2009 Nat Protoc
An efficient platform for screening expression and crystallization of glycoproteins produced in human cells.
Lee JE, Fusco ML, Saphire EO.
Jan 1, 2009 Waltham: Academic Press
The Role of Invariant Natural Killer T Cells in Autoimmune Diseases
Wingender G, Kronenberg M
Jan 1, 2009 Future Virol
Ebolavirus glycoprotein structure and mechanism of entry.
Lee JE, Saphire EO.
Jul 11, 2008 Nature
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor.
Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO.
Nov 17, 2007 J Mol Biol
Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain.
Lee JE, Kuehne A, Abelson DM, Fusco ML, Hart MK, Saphire EO.
Apr 21, 2007 J Mol Biol
Structure of a high-affinity “mimotope” peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies.
Saphire EO, Montero M, Menendez A, van Houten NE, Irving MB, Pantophlet R, Zwick MB, Parren PW, Burton DR, Scott JK, Wilson IA.
Apr 5, 2007 The New England Journal of Medicine
Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease
Vijayanand, P.*, Seumois, G., Pickard, C., Powell, R.M., Angco, G., Sammut, D., Gadola, S.D., Friedmann, P.S., and Djukanovic, R.
May 16, 2006 J Virol
Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
Cárdenas WB, Loo YM, Gale M Jr, Hartman AL, Kimberlin CR, Martínez-Sobrido L, Saphire EO, Basler CF
  • 1
  • 2
  • 3
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • Contact Us
  • Careers
  • Terms & Conditions
  • Privacy Policy
La Jolla Institute for Immunology

contact@lji.org
9420 Athena Circle
La Jolla, CA 92037

Phone: +1 (858) 752-6500

© 2020 La Jolla Institute for Immunology. All rights reserved.LJI is a 501(c)3 tax-exempt organization.Federal Tax ID Number 33-0328688

Designed and Developed by Creative Science Labs

Location:
We use cookies to analyze site traffic and to ensure that we give you the best experience on our website. We do not sell data obtained through the use of cookies. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.OkPrivacy policy